New glossary of terms used in regenerative medicine: standardization continues to emerge as regenerative medicine matures.

Abstract:

:Regenerative medicine is an evolving, cross-disciplinary, international field that, as a result, uses terms that are either not widely understood, or may have a number of different meanings. Many stakeholders have identified this lack of clarity as a potential barrier to effective communication within the field. To address this, BSI British Standards, supported by the UK Department for Innovation, Universities and Skills (DIUS), was commissioned to develop guidance on the definitions of terms used within regenerative medicine. The resulting document aims to provide clear consensus terminology to improve communication and facilitate a common understanding for a broad range of potential users.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Sheridan B,Harris N

doi

10.2217/rme.09.34

subject

Has Abstract

pub_date

2009-07-01 00:00:00

pages

621-2

issue

4

eissn

1746-0751

issn

1746-076X

journal_volume

4

pub_type

杂志文章
  • Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

    abstract:AIM:To evaluate the in vitro immunogenic and immunomodulatory properties of induced pluripotent stem cells (iPSCs) compared with bone marrow-derived mesenchymal stromal cells (MSCs). MATERIALS & METHODS:Mouse embryonic fibroblasts (MEFs) were isolated from C3HeB/FeJ and C57BL/6J mice, and reprogrammed to generate iPSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.29

    authors: Schnabel LV,Abratte CM,Schimenti JC,Felippe MJ,Cassano JM,Southard TL,Cross JA,Fortier LA

    更新日期:2014-01-01 00:00:00

  • In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

    abstract::Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro. Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potenti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0067

    authors: Nieto-Nicolau N,Martín-Antonio B,Müller-Sánchez C,Casaroli-Marano RP

    更新日期:2020-03-01 00:00:00

  • Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

    abstract::Parkinson's disease and Alzheimer's disease are the most common neurodegenerative diseases in the elderly population. Given that age is the most important risk factor in these diseases, the number of patients is expected to rise dramatically in the coming years. Therefore, an effective therapy for these diseases is hi...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.2.4.425

    authors: Korecka JA,Verhaagen J,Hol EM

    更新日期:2007-07-01 00:00:00

  • From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.

    abstract::Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational intere...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.70

    authors: Ricordi C,Inverardi L,Domínguez-Bendala J

    更新日期:2012-11-01 00:00:00

  • A xenobiotic-free culture system for human limbal epithelial stem cells.

    abstract:AIMS:Murine 3T3 feeder cells are commonly used for stem cell expansion. Although 'feeder-free' systems are being developed for a variety of stem cells including embryonic, the use of feeder cells currently remains optimal for the expansion of epithelial stem cells. In this study, MRC-5, a human embryonic fibroblast cel...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.6.919

    authors: Notara M,Haddow DB,MacNeil S,Daniels JT

    更新日期:2007-11-01 00:00:00

  • Organization profile: genetics policy institute.

    abstract::Genetics Policy Institute (GPI) is a nonprofit, public interest organization recognized as a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. Since GPI's inception in 2003, its mission has focused on establishing a positive policy, regulatory and societal fra...

    journal_title:Regenerative medicine

    pub_type: 新闻

    doi:10.2217/rme.09.6

    authors: Siegel B

    更新日期:2009-05-01 00:00:00

  • Interview: stemming vision loss with stem cells: seeing is believing.

    abstract::Professor Coffey joined the faculty at the University of Oxford in 1987 on completing his doctoral work. In 1989, he was awarded a personal Royal Society Research Fellowship, at the same time moving to the University of Sheffield to establish a new laboratory for retinal transplantation. After 14 years at the Universi...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.33

    authors: Coffey P

    更新日期:2009-07-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00

  • The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.

    abstract::The UK Stem Cell Bank is a UK Research Council-funded initiative that aims to provide ethically sourced and quality controlled stocks of cells for researchers and also establish seed stocks of cell lines for clinical trials. Whilst the Bank is prohibited from carrying out basic stem cell research (to avoid conflicts o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.139

    authors: Stacey G,Hunt CJ

    更新日期:2006-01-01 00:00:00

  • Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.

    abstract::Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0065

    authors: Chan S

    更新日期:2017-10-01 00:00:00

  • Conference Report: 6th Annual International Symposium on Regenerative Rehabilitation.

    abstract::The 6th International Symposium on Regenerative Rehabilitation, hosted by the Alliance for Regenerative Rehabilitation Research and Training (AR3T), included a preconference meeting of institutional representatives of the International Consortium of Regenerative Rehabilitation, keynote talks from distinguished scienti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0026

    authors: Loghmani MT,Roche JA

    更新日期:2018-06-01 00:00:00

  • Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

    abstract::Dimethyl sulfoxide (DMSO) is the cryoprotectant of choice for most animal cell systems since the early history of cryopreservation. It has been used for decades in many thousands of cell transplants. These treatments would not have taken place without suitable sources of DMSO that enabled stable and safe storage of bo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0145

    authors: Awan M,Buriak I,Fleck R,Fuller B,Goltsev A,Kerby J,Lowdell M,Mericka P,Petrenko A,Petrenko Y,Rogulska O,Stolzing A,Stacey GN

    更新日期:2020-03-01 00:00:00

  • Pluripotent stem cells: the last 10 years.

    abstract::Pluripotent stem cells (PSCs) can differentiate into virtually any cell type in the body, making them attractive for both regenerative medicine and drug discovery. Over the past 10 years, technological advances and innovative platforms have yielded first-in-man PSC-based clinical trials and opened up new approaches fo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0117

    authors: Kimbrel EA,Lanza R

    更新日期:2016-12-01 00:00:00

  • Research progress and prospects of tissue engineering scaffolds for spinal cord injury repair and protection.

    abstract::Spinal cord injury (SCI) is one of the leading causes of global disability. However, there are currently no effective clinical treatments for SCI. Repair of SCI is essential but poses great challenges. As a comprehensive treatment program combining biological scaffolds, seed cells and drugs or biological factors, tiss...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0156

    authors: Ma Z,Lu Y,Yang Y,Wang J,Kang X

    更新日期:2019-09-01 00:00:00

  • First endocavitary treatment with cord blood platelet gel for perianal fistula.

    abstract::Cord blood platelet gel is prepared by activation of coagulation in a platelet concentrate obtained from cord blood. During the process of clot formation, platelet alpha-granules release growth factors that promote tissue repair. However, in the form of gel, it is not possible to inject it into small, narrow and deep ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0074

    authors: Bisceglia G,Santodirocco M,Faienza A,Mastrodonato N,Urbano F,Totaro A,Bazzocchi F,Mauro LD

    更新日期:2020-01-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • Safety and efficacy of cell therapies administered in the acute and subacute stages after stroke: a meta-analysis.

    abstract:AIMS:To evaluate the safety and efficacy of cell therapies administered acutely/sub-acutely after stroke. METHODS:Five databases were searched for studies examining the safety/efficacy of cell therapies administered ≤90 days post-stroke. Reporting quality and adherence to research guidelines were evaluated. Safety and...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.2217/rme-2016-0063

    authors: Unsworth DJ,Mathias JL,Dorstyn DS

    更新日期:2016-10-01 00:00:00

  • Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance.

    abstract::The thymus is required for generation of a self-tolerant, self-restricted T-cell repertoire. The capacity to manipulate or replace thymus function therapeutically would be beneficial in a variety of clinical settings, including for improving recovery following bone marrow transplantation, restoring immune system funct...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.15.8

    authors: Bredenkamp N,Jin X,Liu D,O'Neill KE,Manley NR,Blackburn CC

    更新日期:2015-01-01 00:00:00

  • Cell-based therapy for the treatment of female stress urinary incontinence: an early cost-effectiveness analysis.

    abstract:AIM:To perform an early cost-effectiveness analysis of in vitro expanded myoblasts (IVM) and minced myofibers versus midurethral slings (MUS) for surgical treatment of female stress urinary incontinence. METHODS:Cost-effectiveness and sensitivity analyses were performed using a decision tree comprising previously publ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0124

    authors: Vilsbøll AW,Mouritsen JM,Jensen LP,Bødker N,Holst AW,Pennisi CP,Ehlers L

    更新日期:2018-04-01 00:00:00

  • Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia.

    abstract::Many of the current drug therapies for androgenetic alopecia were discovered serendipitously, with hair growth observed as an off-target effect when drugs were used to treat a different disorder. Subsequently, several studies using cultured cells have enabled identification of hair growth modulators with similar prope...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.87

    authors: Higgins CA,Christiano AM

    更新日期:2014-01-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Chronic ischial tuberosity avulsion nonunion fracture treated with a platelet-rich plasma injection as a bone graft.

    abstract::We present a case of an 18-year-old with a 2-year history of buttock pain who failed extensive treatment for a perceived hamstring strain. Upon evaluation, he was diagnosed with an ischial tuberosity nonunion avulsion fracture. The patient underwent bone grafting via an ultrasound guided leukocyte rich platelet-rich p...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0071

    authors: Stafford CD 2nd,Colberg RE,Nourse AL

    更新日期:2019-05-01 00:00:00

  • Biocompatibility and the efficacy of medical implants.

    abstract::Biocompatibility is key to the performance of any material in a biological environment. This review outlines current opinion on the factors that lead to biocompatibility and focuses on the interactions that occur at the interface between material and environment. The sequence of events, from protein adsorption, cell a...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.6.789

    authors: Shard AG,Tomlins PE

    更新日期:2006-11-01 00:00:00

  • The use of hematopoietic stem cells in autoimmune diseases.

    abstract::Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cycloph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2015-0057

    authors: Ben Nasr M,Bassi R,Usuelli V,Valderrama-Vasquez A,Tezza S,D'Addio F,Fiorina P

    更新日期:2016-06-01 00:00:00

  • Bioactive wound healing, bioaesthetics and biosurgery: three pillars of product development. Interview with Geoff MacKay.

    abstract::Tissue regeneration specialist company Organogenesis Inc. was one of the first biotech companies formed. Incorporated in 1985, the company was originally a spin-off from a research program at MIT. For the first 10-15 years, Organogenesis was heavily research based, but then gradually moved into development. The compan...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/17460751.1.2.169

    authors: MacKay G

    更新日期:2006-03-01 00:00:00

  • Tendon and ligament engineering: from cell biology to in vivo application.

    abstract::Tendons and ligaments are related connective tissues that join muscle to bone and bone to bone, respectively. Tendon and ligament injuries are widely distributed clinical problems in society and while healing of such disorders can occur, the original biological properties of the tissue do not return to normal. In this...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/17460751.1.4.563

    authors: Hoffmann A,Gross G

    更新日期:2006-07-01 00:00:00

  • Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

    abstract::Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were fol...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0069

    authors: Vinet-Jones H,F Darr K

    更新日期:2020-10-01 00:00:00

  • Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers.

    abstract:AIM:We hypothesized that delivery of mesenchymal stem cells (MSCs) in a biomimetic collagen scaffold improves wound healing in a diabetic mouse model. MATERIALS & METHODS:Rolled collagen scaffolds containing MSCs were implanted or applied topically to diabetic C57BL/6 mice with excisional wounds. RESULTS:Rolled scaff...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2015-0045

    authors: Assi R,Foster TR,He H,Stamati K,Bai H,Huang Y,Hyder F,Rothman D,Shu C,Homer-Vanniasinkam S,Cheema U,Dardik A

    更新日期:2016-04-01 00:00:00

  • Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis.

    abstract:AIM:In this study, we have evaluated the therapeutic efficacy of mouse multipotent adult progenitor cells (mMAPCs) in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, and compared it with mouse mesenchymal stem cells (mMSCs). MATERIALS & METHODS:We administered PKH26-labeled mMAP...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0109

    authors: Singh SP,Jadhav SH,Chaturvedi CP,Nityanand S

    更新日期:2017-04-01 00:00:00

  • Modeling biological and economic uncertainty on cell therapy manufacturing: the choice of culture media supplementation.

    abstract:AIM:To evaluate the cost-effectiveness of autologous cell therapy manufacturing in xeno-free conditions. MATERIALS & METHODS:Published data on the isolation and expansion of mesenchymal stem/stromal cells introduced donor, multipassage and culture media variability on cell yields and process times on adherent culture ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0034

    authors: Bandeiras C,Cabral JM,Finkelstein SN,Ferreira FC

    更新日期:2018-12-01 00:00:00